Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Halma has acquired Surgistar, a medical devices business in the healthcare sector in the UK, for $X. Surgistar develops and supplies medical device solutions used by clinicians, supporting patient care workflows across healthcare facilities. Halma’s strategic acquisition expands its medical devices portfolio through a bolt on acquisition focused on complementary products and capabilities. The Surgistar acquisition is part of healthcare M&A activity by a strategic buyer, structured as a bolt on acquisition to accelerate growth. Deal status is announced, with terms and closing timing expected to be confirmed as part of the strategic acquisition process.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026